Eyconis Appoints Dr. Mark J. Bachleda As Chief Executive Officer
19 Sep 2024 //
GLOBENEWSWIRE
New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets
29 Jan 2024 //
GLOBENEWSWIRE
19 Sep 2024 //
GLOBENEWSWIRE
29 Jan 2024 //
GLOBENEWSWIRE
Market Place
Sourcing Support